RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      The effect of 4-hexylresorinol administration on NAD+ level and SIRT activity in Saos-2 cells

      한글로보기

      https://www.riss.kr/link?id=A107945668

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Background4-hexylresorcinol (4HR) has been shown to have anti-oxidant activity similar to that of resveratrol. As resveratrol increases sirtuin (SIRT) activity, 4HR might behave similarly to resveratrol.


      MethodIn this study, the expression levels of SIRT1, SIRT3, and SIRT6 were evaluated after 4HR administration (1–100 μM). As NAD+ is a substrate for SIRTs, its levels with SIRT activity were also studied.


      ResultsIn the results, SIRT3 (100 μM at 24 h) and SIRT6 (1–100 μM at 24 h and 10 μM at 8 h) were shown to have significantly higher expression levels compared to untreated control (p < 0.05). Pan-SIRT activity and the NAD+ level was significantly increased compared to that of the untreated control (p < 0.05; 10 and 100 μM at 24 h).


      Conclusion4HR administration increased SIRT activity and the NAD+ level in Saos-2 cells.
      번역하기

      Background4-hexylresorcinol (4HR) has been shown to have anti-oxidant activity similar to that of resveratrol. As resveratrol increases sirtuin (SIRT) activity, 4HR might behave similarly to resveratrol. MethodIn this study, the expression levels of...

      Background4-hexylresorcinol (4HR) has been shown to have anti-oxidant activity similar to that of resveratrol. As resveratrol increases sirtuin (SIRT) activity, 4HR might behave similarly to resveratrol.


      MethodIn this study, the expression levels of SIRT1, SIRT3, and SIRT6 were evaluated after 4HR administration (1–100 μM). As NAD+ is a substrate for SIRTs, its levels with SIRT activity were also studied.


      ResultsIn the results, SIRT3 (100 μM at 24 h) and SIRT6 (1–100 μM at 24 h and 10 μM at 8 h) were shown to have significantly higher expression levels compared to untreated control (p < 0.05). Pan-SIRT activity and the NAD+ level was significantly increased compared to that of the untreated control (p < 0.05; 10 and 100 μM at 24 h).


      Conclusion4HR administration increased SIRT activity and the NAD+ level in Saos-2 cells.

      더보기

      참고문헌 (Reference)

      1 Jung RC, "Use of a hexylresorcinol tablet in the enema treatment of whipworm infection" 3 (3): 918-921, 1954

      2 Chen Y, "Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS" 12 (12): 534-541, 2011

      3 Zhang P, "Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion" 111 (111): 10684-10689, 2014

      4 Nicola J. Curtin, "Therapeutic applications of PARP inhibitors: Anticancer therapy and beyond" Elsevier BV 34 (34): 1217-1256, 2013

      5 Min-Joong Kim, "The long-term evaluation of the prognosis of implants with acid-etched surfaces sandblasted with alumina: a retrospective clinical study" 대한악안면성형재건외과학회 42 (42): 1-9, 2020

      6 Veader Leonard, "The Significance of Hexylresorcinol and Its Homologues in Relation to the Problem of Internal Antisepsis" American Association for the Advancement of Science (AAAS) 62 (62): 408-412, 1925

      7 Konrad T. Howitz, "Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan" Springer Science and Business Media LLC 425 (425): 191-196, 2003

      8 Yang Y, "Sirtuins, Proteins and Cell Regulation" Springer 1-28, 2016

      9 Cantó C, "Sirtuins, Proteins and Cell Regulation" Springer 71-104, 2016

      10 Rogina B, "Sir2 mediates longevity in the fly through a pathway related to calorie restriction" 101 (101): 15998-16003, 2004

      1 Jung RC, "Use of a hexylresorcinol tablet in the enema treatment of whipworm infection" 3 (3): 918-921, 1954

      2 Chen Y, "Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS" 12 (12): 534-541, 2011

      3 Zhang P, "Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion" 111 (111): 10684-10689, 2014

      4 Nicola J. Curtin, "Therapeutic applications of PARP inhibitors: Anticancer therapy and beyond" Elsevier BV 34 (34): 1217-1256, 2013

      5 Min-Joong Kim, "The long-term evaluation of the prognosis of implants with acid-etched surfaces sandblasted with alumina: a retrospective clinical study" 대한악안면성형재건외과학회 42 (42): 1-9, 2020

      6 Veader Leonard, "The Significance of Hexylresorcinol and Its Homologues in Relation to the Problem of Internal Antisepsis" American Association for the Advancement of Science (AAAS) 62 (62): 408-412, 1925

      7 Konrad T. Howitz, "Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan" Springer Science and Business Media LLC 425 (425): 191-196, 2003

      8 Yang Y, "Sirtuins, Proteins and Cell Regulation" Springer 1-28, 2016

      9 Cantó C, "Sirtuins, Proteins and Cell Regulation" Springer 71-104, 2016

      10 Rogina B, "Sir2 mediates longevity in the fly through a pathway related to calorie restriction" 101 (101): 15998-16003, 2004

      11 Kanfi Y, "SIRT6 protects against pathological damage caused by diet-induced obesity" 9 (9): 162-173, 2010

      12 Kozubek A, "Resorcinolic lipids, the natural non-isoprenoid phenolic amphiphiles and their biological activity" 99 (99): 1-26, 1999

      13 "PubChem"

      14 Song JY, "Porcine bone incorporated with 4-hexylresorcinol increases new bone formation by suppression of the nuclear factor kappa B signaling pathway" 29 (29): 1983-1990, 2018

      15 Heinz-Juergen Hausser, "Phenotypic instability of Saos-2 cells in long-term culture" Elsevier BV 333 (333): 216-222, 2005

      16 López-Gómez L, "Nutraceuticals and enteric glial cells" 26 (26): 3762-, 2021

      17 Canto C, "Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle" 11 (11): 213-219, 2010

      18 Jang JK, "Inhibitory effects of 4-hexylresorcinol on root resorption induced by orthodontic tooth movement" 10 (10): 6313-, 2020

      19 Kim DW, "Increased level of vascular endothelial growth factors by 4-hexylresorcinol is mediated by transforming growth factor-β1 and accelerates capillary regeneration in the burns in diabetic animals" 21 (21): 3473-, 2020

      20 Kim JY, "Increased expression of TGF-β1 by 4-hexylresorcinol was due to the upregulation of mitochondrial stress and sirtuin activity in human endothelial cells" 11 (11): 9128-, 2021

      21 Kincaid B, "Forever young : SIRT3 a shield against mitochondrial meltdown, aging, and neurodegeneration" 5 : 48-, 2013

      22 Chau MD, "Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway" 107 (107): 12553-12558, 2010

      23 Kushneruk MA, "Factors inducing transition from growth to dormancy in rhizobacteria Azospirillum brasilense" 82 (82): 563-570, 2013

      24 Michishita E, "Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins" 16 (16): 4623-4635, 2005

      25 Yen GC, "Effects of resveratrol and 4-hexylresorcinol on hydrogen peroxide-induced oxidative DNA damage in human lymphocytes" 37 (37): 509-514, 2003

      26 Kawahara TL, "Dynamic chromatin localization of Sirt6 shapes stress-and aging-related transcriptional networks" 7 (7): e1002153-, 2011

      27 권대근, "Current status of surgery first approach (part II): precautions and complications" 대한악안면성형재건외과학회 41 (41): 1-3, 2019

      28 Lee SW, "Cisplatin and 4-hexylresorcinol synergise to decrease metastasis and increase survival rate in an oral mucosal melanoma xenograft model : A preliminary study" 34 (34): 1595-1603, 2013

      29 Civitarese AE, "Calorie restriction increases muscle mitochondrial biogenesis in healthy humans" 4 (4): e76-, 2007

      30 Chang JH, "Alleviation of oxidative stress in dental pulp cells following 4-hexylresorcinol administration in a rat model" 11 (11): 3637-, 2021

      31 Benjamin J. Martin, "A randomized controlled trial evaluating antioxidant–essential oil gel as a treatment for gingivitis in orthodontic patients" The Angle Orthodontist (EH Angle Education & Research Foundation) 86 (86): 407-412, 2016

      32 Kim YS, "4-hexylresorcinol-induced protein expression changes in human umbilical cord vein endothelial cells as determined by immunoprecipitation high-performance liquid chromatography" 15 (15): e0243975-, 2020

      33 Kim SG, "4-hexylresorcinol exerts antitumor effects via suppression of calcium oscillation and its antitumor effects are inhibited by calcium channel blockers" 29 (29): 1835-1840, 2013

      34 Min-Keun Kim, "4-Hexylresorcinol-in duced angiogenesis potential in human endothelial cells" 대한악안면성형재건외과학회 42 (42): 1-11, 2020

      35 Jo YY, "4-Hexylresorcinol and silk sericin increase the expression of vascular endothelial growth factor via different pathways" 9 (9): 3448-, 2019

      더보기

      동일학술지(권/호) 다른 논문

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2027 평가예정 재인증평가 신청대상 (재인증)
      2021-01-01 평가 등재학술지 유지 (재인증) KCI등재
      2018-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2015-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2014-03-20 학술지명변경 한글명 : 대한악안면성형재건외과학회지 -> Maxillofacial Plastic Reconstructive Surgery
      외국어명 : The Journal of Korean Association of Maxillofacial Plastic and Reconstructive Surgeons -> Maxillofacial Plastic Reconstructive Surgery
      KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2004-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2003-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2002-01-01 평가 등재후보학술지 유지 (등재후보1차) KCI등재후보
      1999-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.23 0.23 0.18
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.12 0.09 0.443 0.1
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼